FIM
Freedom Investment Management Portfolio holdings
AUM
$1.25B
This Quarter Return
+3.26%
1 Year Return
+17.79%
3 Year Return
+58.4%
5 Year Return
+95.43%
10 Year Return
+184.45%
AUM
$1.66B
AUM Growth
+$1.66B
(-15%)
Cap. Flow
-$321M
Cap. Flow
% of AUM
-19.36%
Top 10 Holdings %
Top 10 Hldgs %
31.24%
Holding
1,324
New
213
Increased
372
Reduced
361
Closed
378
Top Buys
| 1 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
$191M |
| 2 |
Vanguard Real Estate ETF
VNQ
|
$45.4M |
| 3 |
iShares TIPS Bond ETF
TIP
|
$25.3M |
| 4 |
iShares Select Dividend ETF
DVY
|
$7.5M |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
$4.74M |
Top Sells
Sector Composition
| 1 | Healthcare | 9.41% |
| 2 | Technology | 8.81% |
| 3 | Financials | 5.81% |
| 4 | Industrials | 5.45% |
| 5 | Consumer Discretionary | 4.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
First American
FAF
$6.63B
| $2.75M | 0.17% |
53,134
+3,270
| +7% | +$169K |
|
102
Hanesbrands
HBI
$2.17B
| $2.73M | 0.16% |
123,736
-1,762
| -1% | -$38.8K |
|
|
BSJI
103
DELISTED
Invesco BulletShares 2018 High Yield Corporate Bond ETF
BSJI
| $2.72M | 0.16% |
108,179
+7,132
| +7% | +$179K |
|
104
Illumina
ILMN
$15.2B
| $2.7M | 0.16% |
9,676
+2,797
| +41% | +$781K |
|
|
BSJJ
105
DELISTED
Invesco BulletShares 2019 High Yield Corporate Bond ETF
BSJJ
| $2.7M | 0.16% |
111,599
+7,705
| +7% | +$186K |
|
|
BSJK
106
DELISTED
Invesco BulletShares 2020 High Yield Corporate Bond ETF
BSJK
| $2.69M | 0.16% |
110,933
+7,950
| +8% | +$193K |
|
107
BioMarin Pharmaceuticals
BMRN
$11.3B
| $2.65M | 0.16% |
28,122
+9,593
| +52% | +$904K |
|
108
Smith & Nephew
SNN
$16.2B
| $2.64M | 0.16% |
70,251
+8,307
| +13% | +$312K |
|
109
Idexx Laboratories
IDXX
$50.7B
| $2.61M | 0.16% |
+11,974
| New | +$2.61M |
|
110
Medifast
MED
$153M
| $2.6M | 0.16% |
16,256
-3,635
| -18% | -$582K |
|
111
Jazz Pharmaceuticals
JAZZ
$7.99B
| $2.6M | 0.16% |
15,061
+6,636
| +79% | +$1.14M |
|
112
Generac Holdings
GNRC
$10.3B
| $2.58M | 0.16% |
49,949
+1,471
| +3% | +$76.1K |
|
|
ALXN
113
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $2.58M | 0.16% |
20,812
+14,056
| +208% | +$1.75M |
|
114
Snap-on
SNA
$16.8B
| $2.58M | 0.16% |
16,055
+5,634
| +54% | +$905K |
|
115
Fiserv
FI
$74.3B
| $2.56M | 0.15% |
34,588
+2,931
| +9% | +$217K |
|
116
Regeneron Pharmaceuticals
REGN
$59.8B
| $2.53M | 0.15% |
7,337
+4,171
| +132% | +$1.44M |
|
117
Nike
NKE
$110B
| $2.53M | 0.15% |
31,695
-22,217
| -41% | -$1.77M |
|
118
Cigna
CI
$80.2B
| $2.52M | 0.15% |
14,852
+5,907
| +66% | +$1M |
|
119
Johnson & Johnson
JNJ
$429B
| $2.51M | 0.15% |
20,679
-4,685
| -18% | -$568K |
|
120
Invesco Fundamental High Yield Corporate Bond ETF
PHB
$352M
| $2.5M | 0.15% |
136,669
-4,255
| -3% | -$77.8K |
|
121
SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.4B
| $2.5M | 0.15% |
46,251
+29,017
| +168% | -$294K |
|
122
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$16.1B
| $2.48M | 0.15% |
23,376
-1,429
| -6% | -$152K |
|
|
ZAGG
123
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $2.48M | 0.15% |
143,279
+38,704
| +37% | +$670K |
|
124
Applied Materials
AMAT
$124B
| $2.48M | 0.15% |
53,646
+26,083
| +95% | +$1.2M |
|
125
Vertex Pharmaceuticals
VRTX
$102B
| $2.47M | 0.15% |
14,543
-43
| -0.3% | -$7.31K |
|